PME signs 7-year, $20M Contract with Gundersen Health System

16 May 2023; Company Announcement - Gundersen Final - Acrobat pdf 437k Highlights PME signs 7-year, AUD $20M deal with Gundersen Health System (“Gundersen”) Visage to replace legacy PACS throughout the Gundersen network Contract is for “full stack” - Visage 7 Viewer, Visage 7 Open Archive and Visage 7 Workflow Visage 7 platform to be implemented in the cloud Continues PME’s rapid expansion into North American integrated delivery networks Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a $20M, 7-year contract with Gundersen Health System, a not-for-profit integrated delivery network (IDN), comprising seven (7) hospitals and 65 clinics across Wisconsin, Minnesota and Iowa. Based on a transactional licensing model, the contract will see the company’s cloud-engineered Visage 7 Enterprise Imaging Platform (‘Visage 7’), including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout Gundersen providing a unified diagnostic imaging platform across the network. Planning for the rollout is to commence immediately and will be based on Visage’s proven cloud-based implementation process, with initial go-lives targeted for the second half of the 2023 calendar year. “IDNs are the largest market segment in North America and we continue to build strong momentum in this key market with this, our fifth material IDN contract in the last 12 months, “ said Dr Sam Hupert, Pro Medicus CEO. “It reinforces our belief that our solution is equally well suited to IDNs of all sizes, making our total addressable market very significant.” Gundersen joins the increasing list of consecutive Visage 7 clients to opt for a fully cloud-engineered solution, a trend that has now become the standard in the North

PME Signs 8-Year, $12M Contract with Samaritan Health Services

30 January 2023; PME Signs Samaritan Health Services - Acrobat pdf 114k Highlights PME signs 8-year, AUD $12M deal with Oregon-based Samaritan Health Services Visage to replace legacy PACS throughout the Samaritan Health Services network Contract includes Visage 7 Open Archive and Visage 7 Workflow in addition to Visage 7 Viewer Visage 7 platform to be installed in the cloud Continues PME’s rapid expansion into North American integrated delivery networks Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a $12M, 8-year contract with Oregon- based Samaritan (“Samaritan”) Health Services, a community-based, integrated delivery network (IDN) based in Oregon. Samaritan has five hospitals in the mid-Willamette Valley and central Oregon Coast. Based on a transactional licensing model, the contract will see the company’s cloud-engineered Visage 7 Enterprise Imaging Platform (‘Visage 7’), including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout Samaritan providing a unified diagnostic imaging platform across the network. Planning for the rollout is to commence immediately and will be based on Visage’s proven cloud-based implementation process, with initial go-lives targeted for the second half of the 2023 calendar year. “Samaritan joins our growing list of IDN clients and will reinforce our strong presence in the Northwest region of the United States,” said Dr Sam Hupert, Pro Medicus CEO. “IDNs are the largest market segment in North America, and this is our fifth material IDN contract in the last 12 months.” Samaritan has opted for a fully cloud-based solution, a trend that has continued to spread across the North American healthcare IT market. “This deal represents another “full-stack” Visage 7 solution comprising all three Visage products

PME Signs 7-year, $25M Contract with University of Washington’s UW Medicine

20 January 2023; Company Announcement - UW Medicine - Acrobat pdf 115k Highlights PME signs 7-year, AUD $25M deal with Seattle-based UW Medicine Visage to replace legacy PACS throughout the UW Medicine network Contract includes Visage 7 Open Archive and Visage 7 Workflow in addition to Visage 7 Viewer Visage 7 platform to be fully deployed in the cloud Continues PME’s rapid expansion into North American Tier 1 academic institutions Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly- owned U.S. subsidiary, Visage Imaging, Inc., has signed a $25M, 7-year contract with the University of Washington’s UW Medicine, a Tier 1 academic health system based in Seattle, Washington. UW Medicine has multiple campuses throughout the Seattle area and employs 29,000 healthcare professionals, researchers, and educators. It is also the home of the highly regarded University of Washington School of Medicine. Based on a transactional licensing model, the contract will see the company’s cloud-engineered Visage 7 Enterprise Imaging Platform (‘Visage 7’), including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout UW Medicine providing a unified diagnostic imaging platform across the network. Planning for the rollout is to commence immediately and will be based on Visage’s proven cloud-based migration and implementation process, with initial go-lives targeted for the second half of the 2023 calendar year. UW Medicine has opted for a fully cloud-based solution, a trend that has taken a major foothold in the North American healthcare IT market. “UW Medicine joins our growing list of Tier 1 academic clients and will provide us with a strong presence in the Northwest region of the United States,” said Dr Sam Hupert, Pro Medicus CEO. “With its highly regarded

PME Signs 7-year $15M Contract with Luminis Health

22 December 2022; Company Announcement - Luminis Health - Acrobat pdf 115k Highlights PME signs 7-year, AUD $15M deal with Luminis Health Visage to replace legacy PACS throughout the Luminis Health network Contract includes Visage 7 Open Archive and Visage 7 Workflow, in addition to Visage 7 Viewer Visage 7 platform to be installed in the cloud Continues PME’s rapid expansion into North American integrated delivery networks Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a $15M 7-year contract with Luminis Health. Luminis Health, an Annapolis, Maryland based not-for-profit integrated delivery network (IDN) serves communities in central Maryland from Washington, DC to Delaware. Based on a transactional licensing model, the contract will see the company’s cloud-engineered Visage 7 Enterprise Imaging Platform (‘Visage 7’), including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout Luminis Health providing a unified diagnostic imaging platform across the network. Planning for the rollout is to commence immediately and will be based on Visage’s proven cloud-based implementation process with initial go-lives targeted for the first half of the 2023 calendar year. “IDN’s constitute the largest market segment in North America and we continue to build momentum in this segment with this, our fourth material IDN contract in the last 12 months,“ said Dr Sam Hupert, Pro Medicus CEO. “It also serves to highlight that our solution is equally well suited to mid-sized IDN’s as it is to the large ones, confirming our view that our total addressable market in the IDN space is very significant." Luminis Health joins an increasing number of new Visage clients to opt for a fully

PME Signs Two Contract Renewals with a Combined Minimum Value of A$47M

14 June 2022; Company Announcement - Sutter Health and WellSpan Health Contract Renewals - Acrobat pdf 113k Highlights Signs two contract renewals with a combined minimum value of A$47M Sutter Health renews for seven years - WellSpan Health for five Contract renewals transaction-based with potential upside Renewals negotiated at an increased fee per transaction Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed two key contract renewals with a combined value of A$47M. Sutter Health, a large IDN based in Sacramento, California has signed for a further seven years, and WellSpan Health based in Pennsylvania for a further five. Both deals are transaction-based with committed minimums and have been negotiated at a higher per transaction cost than their original contracts. "The industry norm for renewals is for short extensions to the original contract at the same or lower price," said Dr Sam Hupert, Pro Medicus CEO. "The fact that our clients have renewed for a full or longer term contract term at an increased price supports our belief that the Visage solution delivers unparalleled value both in terms of financial and clinical ROI." "Whilst it is still early days, our renewal success rate sends a positive message to the market and helps build on the network effect that we have been experiencing."

PME Signs 8-year, $32M Contract with Inova Health System

8 April 2022; Company Announcement - Inova Health System - Acrobat pdf 90k Highlights PME signs 8-year, AUD $32M deal with Inova Health System Visage to replace two legacy PACS systems Contract to include Fairfax Radiology - a joint venture between Fairfax Radiological Consultants. and Inova Health System Visage 7 platform to be implemented in the public cloud Extends PME’s rapidly growing footprint in the North American Integrated Delivery Network (IDN) market Transaction-based model with potential upsideT Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a $32M, 8-year contract with Inova Health System, the leading nonprofit healthcare provider in Northern Virginia. Inova’s 20,000+ team members provide more than two million patient visits each year through an integrated network of hospitals, primary and specialty care practices, emergency and urgent care centers, outpatient services and destination institutes. Based on a transactional licensing model, the contract will see the company’s Visage 7 Enterprise Imaging Platform (“Visage 7”) implemented throughout Inova and Fairfax Radiology, providing a unified diagnostic imaging platform across both networks. Planning for the rollout is to commence immediately, with initial go-lives targeted for the second half of the calendar year. The implementation will be fully deployed in the public cloud. “This is our fourth major contract in the IDN space in less than 18 months which further underpins the strong momentum we continue to build not only in this segment of market but also the North American market as a whole,” said Dr Sam Hupert, Pro Medicus CEO. Inova also joins an increasing number of Visage clients to opt for a fully cloud-deployed solution, a trend that has taken a foothold in the

Dr Sam Hupert | Interview

CEO Interview - Intermountain 14 Jan 2021 - Acrobat pdf 266k 14 January 2021 Interview with Pro Medicus CEO, Dr Sam Hupert, where he discussed: A$40M - 7 year Intermountain Healthcare contract Momentum behind Visage in the Cloud offering Recent wins, competitive position and pipeline

PME Signs A$40M – 7 Year Contract with Intermountain Healthcare

14 January 2021; Company Announcement - PME Announces Intermountain 14 JAN 2021 - Acrobat pdf 119k Highlights PME signs 7-year, A$40M deal with Intermountain Healthcare Intermountain is the largest healthcare provider in the Intermountain West (Utah, Idaho, Nevada) Visage to replace legacy PACS and other specialty systems across their 24 hospitals and more than 200 clinics Contract includes the Visage 7 Viewer and Visage 7 Open Archive Visage 7 platform to be fully deployed in the public-cloud Extends PME’s leading position in large, regional health systems Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 7-year contract with Salt Lake City based Intermountain Healthcare (“Intermountain”), the largest health system in the State of Utah. Intermountain also provides medical services in the states of Idaho and Nevada making it the largest healthcare provider in the Intermountain West region. The contract, based on a transactional licensing model, will see the company’s Visage 7 Viewer and Visage 7 Open Archive products implemented across all of Intermountain’s radiology and subspecialty imaging departments. The implementation will be fully deployed on Google Cloud Platform (GCP), leveraging Visage’s native, cloud-engineered enterprise imaging technology. Planning for the rollout is to begin in Q3 FY21, with data migration commencing immediately by Visage’s engineering team. The first sites will be scheduled to go-live shortly thereafter. “This is a very important deal for us, not only because of its size and scope, it will provide us with a material footprint in Intermountain West, previously an untapped region for us,” said Dr Sam Hupert, Pro Medicus CEO. “It also validates our decision to engineer Visage 7 from the ground up to be natively cloud capable, with Intermountain

PME Signs A$18M – 5 Year Contract with MedStar Health

17 December 2020; Company Announcement - PME Signs MedStar Health 17 Dec 2020 - Acrobat pdf 107k Highlights PME signs 5-year, A$18M deal with MedStar Health Visage to replace MedStar’s legacy PACS across their 10 hospitals, representing the largest health system in the Maryland/District of Columbia (DC) region Contract is for the full suite of Visage 7 modules – Visage 7 Viewer, Visage 7 Open Archive and Visage 7 Workflow Visage 7 platform to be fully deployed in the public-cloud Extends PME’s rapidly growing footprint in North America Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 5-year contract with MedStar Health (“MedStar”), the largest health system in the Maryland and Washington, D.C. metropolitan region. The contract, based on a transactional licensing model, will see the company’s complete enterprise imaging solution comprising Visage 7 Viewer, Visage 7 Open Archive and Visage 7 Workflow implemented across all of MedStar’s radiology and subspecialty imaging departments including MedStar Georgetown University Hospital. The implementation is notable in that it will provide MedStar with a fully cloud deployed environment on GCP (Google Cloud Platform), leveraging Visage’s native, cloud-engineered enterprise imaging technology. Planning for the rollout is to commence in Q2 FY21 with the first sites scheduled to go-live in Q3 FY21. “MedStar went through an extensive evaluation process including a pilot that not only benchmarked Visage 7 compared to on-premise systems from other vendors, it served to verify the speed of Visage 7 in the public-cloud,” said Dr Sam Hupert, Pro Medicus CEO. “Unlike systems from other vendors, Visage has been developed from the ground up for cloud deployment. Traditionally, our clients have deployed Visage in their own “private-cloud”

PME Signs A$8.5M – 5 Year Renewal Contract with Zwanger-Pesiri

19 November 2020; Company Announcement - ZP Renewal Nov 2020 - Acrobat pdf 154k Highlights PME signs 5-year renewal contract with Zwanger-Pesiri  Zwanger-Pesiri one of the largest private outpatient radiology providers in the U.S.  Transaction-based model with potential upside  Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 5-year renewal contract with Long Island based Zwanger-Pesiri, one of the largest private outpatient radiology providers in the U.S..  The contract, based on a transaction-based licensing model, will see the company’s Visage 7 technology continued to be used across all Zwanger-Pesiri locations for the next 5 years.  “We have had a great partnership with Visage over the preceding 5 years,” said Dr Steve Mendelsohn, CEO of Zwanger-Pesiri. “The speed and capabilities of their software is unrivalled in the market. Since implementing it 5 years ago, we have experienced significant increases in radiologist productivity and clinical accuracy which has underpinned our substantial growth over that time.”  “We are very pleased to have played such a key role in Zwanger-Pesiri’s growth over the past 5 years,” said Dr Sam Hupert, Pro Medicus CEO. “We believe our solution provides the best return on investment of any system in the market from both financial and clinical perspectives. We think the results we achieved at Zwanger-Persiri is validation of that.”  Authorised by the Board of Pro Medicus Limited.

Go to Top